These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31800724)

  • 1. Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function.
    Fernandes F; Antunes MO; Hotta VT; Rochitte CE; Mady C
    Arq Bras Cardiol; 2019 Nov; 113(5):979-987. PubMed ID: 31800724
    [No Abstract]   [Full Text] [Related]  

  • 2. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic or pathologic hypertrophy: how can we know?
    Lai EJ; Rakowski H
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):919-22. PubMed ID: 24972675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent troponin elevation in a patient with cardiac amyloidosis.
    Kraemer BF; Seizer P; Geisler T; Klingel K; Kandolf R; Lindemann S; Gawaz M
    Clin Cardiol; 2009 Nov; 32(11):E39-42. PubMed ID: 19816977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy.
    Mabru M; Dacher JN; Bauer F
    Arch Cardiovasc Dis; 2010 Jan; 103(1):55-6. PubMed ID: 20142122
    [No Abstract]   [Full Text] [Related]  

  • 6. A tale of two ventricles: unusual causes of left ventricular hypertrophy.
    Pearlamn AS
    Am Heart Hosp J; 2004; 2(4):235-8. PubMed ID: 15538061
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction.
    Madan N; Kalra D
    Rev Cardiovasc Med; 2020 Jun; 21(2):181-190. PubMed ID: 32706207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry disease.
    Yuasa T; Takenaka T; Higuchi K; Uchiyama N; Horizoe Y; Cyaen H; Mizukami N; Takasaki K; Kisanuki A; Miyata M; Ohishi M
    J Echocardiogr; 2017 Dec; 15(4):151-157. PubMed ID: 28674962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and diagnostic key points of left ventricular hypertrophy in adults: insights from the ANMCO Lombardy experience].
    Iacovoni A; De Chiara B; Sormani P; Campana M; Agostini F; Faggiano P; Occhi L; Dadone V; Raineri C; Moreo A; Di Tano G;
    G Ital Cardiol (Rome); 2020 Jun; 21(6):447-456. PubMed ID: 32425191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry disease.
    Nagueh SF
    Heart; 2003 Aug; 89(8):819-20. PubMed ID: 12860841
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrocardiogram in Fabry's disease].
    Jastrzebski M; Petkow-Dimitrow P
    Kardiol Pol; 2008 Jun; 66(6):688-92; discussion 692-3. PubMed ID: 18626840
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy.
    Liu D; Hu K; Niemann M; Herrmann S; Cikes M; Störk S; Gaudron PD; Knop S; Ertl G; Bijnens B; Weidemann F
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):1066-72. PubMed ID: 24100046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical left ventricular hypertrophy revealing a rare cause of heart failure in a man from the Comoros Islands].
    Cautela J; Massoure PL; Roche NC; Taix S; Gil JM; Fourcade L
    Med Sante Trop; 2013; 23(4):390-3. PubMed ID: 24412709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The right ventricle in Fabry disease.
    Kampmann C; Baehner FA; Whybra C; Bajbouj M; Baron K; Knuf M; Wiethoff CM; Trübel H; Beck M
    Acta Paediatr Suppl; 2005 Mar; 94(447):15-8; discussion 9-10. PubMed ID: 15895706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Left ventricular hypertrophy and end-stage renal failure of unknown etiology: Fabry disease?].
    Arévalo-Gómez A; Rivera-García S; López-Muñiz A; Barriales-Villa R
    Rev Clin Esp; 2012 May; 212(5):265-6. PubMed ID: 22112280
    [No Abstract]   [Full Text] [Related]  

  • 17. A rare cause of cardiac decompensation in a patient with left ventricular hypertrophy.
    Mangner N; Gutberlet M; Klingel K; Kandolf R; Schuler G; Linke A
    Clin Res Cardiol; 2012 Nov; 101(11):943-5. PubMed ID: 22645101
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular magnetic resonance in the evaluation of hypertrophic and infiltrative cardiomyopathies.
    O'Hanlon R; Pennell DJ
    Heart Fail Clin; 2009 Jul; 5(3):369-87, vi. PubMed ID: 19564014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac manifestations in Fabry disease].
    Lappegård KT; Aass H
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2395-6. PubMed ID: 11475223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Echocardiography in storage and neuromuscular disorders].
    Stöllberger C; Finsterer J
    Wien Klin Wochenschr; 2001 Jun; 113(11-12):408-15. PubMed ID: 11467086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.